Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host (original) (raw)

• Weinhouse, S. Isozymes in cancer. Cancer Res. 31, 1166–1167 (1971).
  CAS PubMed Google Scholar
• Shih, C. & Weinberg, R. A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29, 161–169 (1982).
  Article CAS PubMed Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983).
  Article CAS PubMed Google Scholar
• Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
  Article PubMed PubMed Central Google Scholar
• Greger, V., Passarge, E., Hopping, W., Messmer, E. & Horsthemke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155–158 (1989).
  Article CAS PubMed Google Scholar
• Sakai, T. et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Amer. J. Hum. Genet. 48, 880–888 (1991).
  CAS Google Scholar
• Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genet. 43, 768–775 (2011).
  Article CAS PubMed Google Scholar
• Boveri, T. Concerning the Origin of Malignant Tumors (Williams and Wilkins, 1929).
  Google Scholar
• Zink, D., Fischer, A. H. & Nickerson, J. A. Nuclear structure in cancer cells. Nature Rev. Cancer 4, 677–687 (2004).
  Article CAS Google Scholar
• Lever, E. & Sheer, D. The role of nuclear organization in cancer. J. Pathol. 220, 114–125 (2010).
  Article CAS PubMed Google Scholar
• Wen, B., Wu, H., Shinkai, Y., Irizarry, R. A. & Feinberg, A. P. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nature Genet. 41, 246–250 (2009).
  Article CAS PubMed Google Scholar
• Zullo, J. M. et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell 149, 1474–1487 (2012).
  Article CAS PubMed Google Scholar
• Hu, S., Cheng, L. & Wen, B. Large chromatin domains in pluripotent and differentiated cells. Acta Biochim. Biophys. Sin. (Shanghai) 44, 48–53 (2012).
  Article CAS Google Scholar
• Peric-Hupkes, D. et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol. Cell 38, 603–613 (2010).
  CAS Google Scholar
• Reddy, K. L., Zullo, J. M., Bertolino, E. & Singh, H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 452, 243–247 (2008).
  Article CAS PubMed Google Scholar
• Chow, K. H., Factor, R. E. & Ullman, K. S. The nuclear envelope environment and its cancer connections. Nature Rev. Cancer 12, 196–209 (2012).
  Article CAS Google Scholar
• Hawkins, R. D. et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479–491 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hon, G. C. et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 22, 246–258 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• McDonald, O. G., Wu, H., Timp, W., Doi, A. & Feinberg, A. P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nature Struct. Mol. Biol. 18, 867–874 (2011).
  Article CAS Google Scholar
• Zhou, V. W., Goren, A. & Bernstein, B. E. Charting histone modifications and the functional organization of mammalian genomes. Nature Rev. Genet. 12, 7–18 (2011).
  Article PubMed CAS Google Scholar
• Wen, B. et al. Euchromatin islands in large heterochromatin domains are enriched for CTCF binding and differentially DNA-methylated regions. BMC Genomics 13, 566 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Berman, B. P. et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nature Genet. 44, 40–46 (2012).
  Article CAS Google Scholar
• Ehrlich, M. DNA hypomethylation in cancer cells. Epigenomics 1, 239–259 (2009).
  Article CAS PubMed Google Scholar
• Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315–322 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68–73 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• De, S. & Michor, F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nature Struct. Mol. Biol. 18, 950–955 (2011).
  Article CAS Google Scholar
• Nestor, C., Ruzov, A., Meehan, R. & Dunican, D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48, 317–319 (2010).
  Article CAS PubMed Google Scholar
• Jin, S.-G., Kadam, S. & Pfeifer, G. P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 38, e125 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, M.-L. et al. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. Clin. Chem. 59, 824–832 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Lian, Christine, G. et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150, 1135–1146 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Zhang, L.-T. et al. Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line. Bioanalysis 5, 839–845 (2013).
  Article CAS PubMed Google Scholar
• Booth, M. J. et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336, 934–937 (2012).
  Article CAS PubMed Google Scholar
• Sun, Z. et al. High-resolution enzymatic mapping of genomic 5-hydroxymethylcytosine in mouse embryonic stem cells. Cell Rep. 3, 567–576 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Wolf, S. F. & Migeon, B. R. Studies of X chromosome DNA methylation in normal human cells. Nature 295, 667–671 (1982).
  Article CAS PubMed Google Scholar
• Bird, A., Taggart, M., Frommer, M., Miller, O. J. & Macleod, D. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40, 91–99 (1985).
  Article CAS PubMed Google Scholar
• Goelz, S. E., Vogelstein, B., Hamilton, S. R. & Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187–190 (1985).
  Article CAS PubMed Google Scholar
• Feinberg, A. P., Gehrke, C. W., Kuo, K. C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159–1161 (1988).
  CAS PubMed Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47–54 (1983).
  Article CAS PubMed Google Scholar
• De Smet, C. et al. The activation of human gene _MAGE_-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl Acad. Sci. USA 93, 7149–7153 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Iacobuzio-Donahue, C. A. et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Amer. J. Pathol. 162, 1151–1162 (2003).
  CAS Google Scholar
• Oshimo, Y. et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int. J. Oncol. 23, 1663–1670 (2003).
  CAS PubMed Google Scholar
• Akiyama, Y., Maesawa, C., Ogasawara, S., Terashima, M. & Masuda, T. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am. J. Pathol. 163, 1911–1919 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, M. et al. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br. J. Cancer 85, 563–567 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Nakamura, N. & Takenaga, K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exper. Metastasis 16, 471–479 (1998).
  Article CAS Google Scholar
• Badal, V. et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77, 6227–6234 (2003).
  Article PubMed PubMed Central Google Scholar
• de Capoa, A. et al. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol. Rep. 10, 545–549 (2003).
  CAS PubMed Google Scholar
• Sato, N. et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 63, 4158–4166 (2003).
  CAS PubMed Google Scholar
• Piyathilake, C. J. et al. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 14, 37–42 (2003).
  Article CAS PubMed Google Scholar
• Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome — biological and translational implications. Nature Rev. Cancer 11, 726–734 (2011).
  Article CAS Google Scholar
• Jones, P. A. et al. De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl Acad. Sci. USA 87, 6117–6121 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Bestor, T. H. Unanswered questions about the role of promoter methylation in carcinogenesis. Ann. NY Acad. Sci. 983, 22–27 (2003).
  Article CAS PubMed Google Scholar
• Hosoya, K. et al. Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis. Cancer Lett. 285, 182–189 (2009).
  Article CAS PubMed Google Scholar
• Levanon, D. et al. Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function. EMBO Mol. Med. 3, 593–604 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hitchins, M. P. et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N. Engl. J. Med. 356, 697–705 (2007).
  Article CAS PubMed Google Scholar
• Hitchins, M. P. & Ward, R. L. Erasure of MLH1 methylation in spermatozoa-implications for epigenetic inheritance. Nature Genet. 39, 1289 (2007).
  Article CAS PubMed Google Scholar
• Bachman, K. E. et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3, 89–95 (2003).
  Article CAS PubMed Google Scholar
• Sproul, D. et al. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc. Natl Acad. Sci. USA 108, 4364–4369 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sproul, D. et al. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol. 13, R84 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Irizarry, R. A. et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res. 18, 780–790 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Irizarry, R. A. et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Genet. 41, 178–186 (2009).
  Article CAS PubMed Google Scholar
• Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet. 41, 1350–1353 (2009).
  Article CAS PubMed Google Scholar
• Teschendorff, A. et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 4, 24 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Corrada Bravo, H., Pihur, V., McCall, M., Irizarry, R. & Leek, J. Gene expression anti-profiles as a basis for accurate universal cancer signatures. BMC Bioinformatics 13, 272 (2012).
  Article PubMed Central Google Scholar
• Wang, G. G., Allis, C. D. & Chi, P. Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling. Trends Mol. Med. 13, 373–380 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Wang, G. G., Allis, C. D. & Chi, P. Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol. Med. 13, 363–372 (2007).
  Article CAS PubMed Google Scholar
• Roberts, C. W. & Orkin, S. H. The SWI/SNF complex--chromatin and cancer. Nature Rev. Cancer 4, 133–142 (2004).
  Article CAS Google Scholar
• Kaplan, N. et al. The DNA-encoded nucleosome organization of a eukaryotic genome. Nature 458, 362–366 (2009).
  Article CAS PubMed Google Scholar
• Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).
  Article CAS PubMed Google Scholar
• Mito, Y., Henikoff, J. G. & Henikoff, S. Genome-scale profiling of histone H3.3 replacement patterns. Nature Genet. 37, 1090–1097 (2005).
  Article CAS PubMed Google Scholar
• Zofall, M. et al. Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs. Nature 461, 419–422 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gardner, K. E., Allis, C. D. & Strahl, B. D. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409, 36–46 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553–560 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Young, N. L. et al. High throughput characterization of combinatorial histone codes. Mol. Cell. Proteomics 8, 2266–2284 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Voigt, P. et al. Asymmetrically modified nucleosomes. Cell 151, 181–193 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ohm, J. E. et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237–242 (2007).
  Article CAS PubMed Google Scholar
• Widschwendter, M. et al. Epigenetic stem cell signature in cancer. Nature Genet. 39, 157–158 (2007).
  Article CAS PubMed Google Scholar
• Chodavarapu, R. K. et al. Relationship between nucleosome positioning and DNA methylation. Nature 466, 388–392 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, W. et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202–206 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Guil, S. & Esteller, M. Cis-acting noncoding RNAs: friends and foes. Nature Struct. Mol. Biol. 19, 1068–1075 (2012).
  Article CAS Google Scholar
• Forbes, S. A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945–D950 (2011).
  Article CAS PubMed Google Scholar
• Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jiao, Y. et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331, 1199–1203 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226–231 (2012).
  Article CAS PubMed Google Scholar
• Krivtsov, A. V. & Armstrong, S. A. MLL translocations, histone modifications and leukaemia stem-cell development. Nature Rev. Cancer 7, 823–833 (2007).
  Article CAS Google Scholar
• Yan, X. J. et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genet. 43, 309–315 (2011).
  Article CAS PubMed Google Scholar
• Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424–2433 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Figueroa, M. E. et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553–567 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kosmider, O. et al. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia. Haematologica 94, 1676–1681 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189–195 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nature Genet. 43, 830–837 (2011).
  Article CAS PubMed Google Scholar
• Bernt, K. M. et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20, 66–78 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235–239 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature Genet. 44, 251–253 (2012).
  Article CAS PubMed Google Scholar
• Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228–231 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wiegand, K. C. et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532–1543 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cooper, D. N., Mort, M., Stenson, P. D., Ball, E. V. & Chuzhanova, N. A. Methylation-mediated deamination of 5-methylcytosine appears to give rise to mutations causing human inherited disease in CpNpG trinucleotides, as well as in CpG dinucleotides. Hum. Genomics 4, 406–410 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153–158 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Schuster-Bockler, B. & Lehner, B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504–507 (2012).
  Article PubMed CAS Google Scholar
• Jiang, Y. et al. Common fragile sites are characterized by histone hypoacetylation. Hum. Mol. Genet. 18, 4501–4512 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Fudenberg, G., Getz, G., Meyerson, M. & Mirny, L. A. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nature Biotech. 29, 1109–1113 (2011).
  Article CAS Google Scholar
• Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. & Caldas, C. Cancer genetics of epigenetic genes. Human Mol. Genet. 16 (Suppl. 1), R28–R49 (2007).
  Article CAS Google Scholar
• Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002).
  Article CAS PubMed Google Scholar
• Iliopoulos, D., Hirsch, H. A. & Struhl, K. An epigenetic switch involving NF-κB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139, 693–706 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yamanaka, S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10, 678–684 (2012).
  Article CAS PubMed Google Scholar
• Suvà, M. L., Riggi, N. & Bernstein, B. E. Epigenetic reprogramming in cancer. Science 339, 1567–1570 (2013).
  Article PubMed CAS Google Scholar
• Minucci, S. & Pelicci, P. G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nature Rev. Cancer 6, 38–51 (2006).
  Article CAS Google Scholar
• Waddington, C. H. The Strategy of the Genes: A Discussion of Some Aspects of Theoretical Biology (Allen & Unwin, 1957).
  Google Scholar
• Raser, J. M. & O'Shea, E. K. Control of stochasticity in eukaryotic gene expression. Science 304, 1811–1814 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  Article CAS PubMed Google Scholar
• Rando, O. J. & Verstrepen, K. J. Timescales of genetic and epigenetic inheritance. Cell 128, 655–668 (2007).
  Article CAS PubMed Google Scholar
• Feinberg, A. P. & Irizarry, R. A. Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc. Natl Acad. Sci. USA 107 (Suppl. 1), 1757–1764 (2010).
  Article CAS PubMed Google Scholar
• Alvarez, H. et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7, e1001356 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shah, M. Y. et al. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 70, 5840–5850 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lande, R. Natural selection and random genetic drift in phenotypic evolution. Evolution 30, 314–334 (1976).
  Article PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Kaneda, A. & Feinberg, A. P. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res. 65, 11236–11240 (2005).
  Article CAS PubMed Google Scholar
• Timp, W., Levchenko, A. & Feinberg, A. P. A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction. Cell Cycle 8, 383–390 (2009).
  Article CAS PubMed Google Scholar
• Kondo, Y. & Issa, J. P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23, 29–39 (2004).
  Article CAS PubMed Google Scholar
• Issa, J. P. Aging, DNA methylation and cancer. Crit. Rev. Oncol. Hematol. 32, 31–43 (1999).
  Article CAS PubMed Google Scholar
• Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359–367 (2013).
  Article CAS PubMed Google Scholar
• Cui, H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753–1755 (2003).
  Article CAS PubMed Google Scholar
• Sakatani, T. et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307, 1976–1978 (2005).
  Article CAS PubMed Google Scholar
• Teschendorff, A. E. & Widschwendter, M. Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions. Bioinformatics 28, 1487–1494 (2012).
  Article CAS PubMed Google Scholar
• Siddique, H., Zou, J. P., Rao, V. N. & Reddy, E. The BRCA2 is a histone acetyltransferase. Oncogene 16, 2283 (1998).
  Article CAS PubMed Google Scholar
• Fuks, F., Milner, J. & Kouzarides, T. BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 17, 2531 (1998).
  Article CAS PubMed Google Scholar
• Esteve, P. O., Chin, H. G. & Pradhan, S. Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters. Proc. Natl Acad. Sci. USA 102, 1000–1005 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Zhu, P. et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5, 455–463 (2004).
  Article CAS PubMed Google Scholar
• Campbell, P. M. & Szyf, M. Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogenesis 24, 17–24 (2003).
  Article CAS PubMed Google Scholar
• Sun, L. et al. Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation. Cell. Signal. 19, 2255–2263 (2007).
  Article CAS PubMed Google Scholar
• Lofton-Day, C. et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem. 54, 414–423 (2008).
  Article CAS PubMed Google Scholar
• Warren, J. D. et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 9, 133 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zou, H. et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol. Biomarkers Prev. 16, 2686–2696 (2007).
  Article CAS PubMed Google Scholar
• Lee, W. H. et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl Acad. Sci. USA 91, 11733–11737 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Zhuang, J. et al. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet. 8, e1002517 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Li, M. et al. Sensitive digital quantification of DNA methylation in clinical samples. Nature Biotech. 27, 858–863 (2009).
  Article CAS Google Scholar
• Silber, J. R., Bobola, M. S., Blank, A. & Chamberlain, M. C. O6-Methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim. Biophys. Acta 1826, 71–82 (2012).
  CAS PubMed PubMed Central Google Scholar
• Rodriguez-Paredes, M. & Esteller, M. Cancer epigenetics reaches mainstream oncology. Nature Med. 17, 330–339 (2011).
  Article CAS PubMed Google Scholar
• Knutson, S. K. et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nature Chem. Biol. 8, 890–896 (2012).
  Article CAS Google Scholar
• Fiskus, W. et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 114, 2733–2743 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Popovici-Muller, J. et al. Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo. ACS Med. Chem. Lett. 3, 850–855 (2012).
  CAS Google Scholar
• Daigle, S. R. et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 20, 53–65 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hull, M. A. Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia. Recent Results Cancer Res. 191, 143–156 (2013).
  Article CAS PubMed Google Scholar
• Kraus, S., Naumov, I. & Arber, N. COX-2 active agents in the chemoprevention of colorectal cancer. Recent Results Cancer Res. 191, 95–103 (2013).
  Article CAS PubMed Google Scholar
• Joshi, P. H. et al. A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology. Clin. Cardiol. 35, 404–409 (2012).
  Article PubMed PubMed Central Google Scholar
• Yuasa, Y. et al. Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk. Int. J. Cancer 131, 2596–2603 (2012).
  Article CAS PubMed Google Scholar
• Kaneda, A. et al. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk. Proc. Natl Acad. Sci. USA 104, 20926–20931 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006).
  Article PubMed CAS Google Scholar
• Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kanai, Y., Ushijima, S., Nakanishi, Y., Sakamoto, M. & Hirohashi, S. Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett. 192, 75–82 (2003).
  Article CAS PubMed Google Scholar
• Tefferi, A. et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 23, 905–911 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Langemeijer, S. M. et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nature Genet. 41, 838–842 (2009).
  Article CAS PubMed Google Scholar
• Yan, H. et al. IDH1 and IDH2 mutations in gliomas. New Engl. J. Med. 360, 765–773 (2009).
  Article CAS PubMed Google Scholar
• Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nature Genet. 43, 875–878 (2011).
  Article CAS PubMed Google Scholar
• Ward, R., Johnson, M., Shridhar, V., van Deursen, J. & Couch, F. J. CBP truncating mutations in ovarian cancer. J. Med. Genet. 42, 514–518 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869–873 (2010).
  Article CAS PubMed Google Scholar
• Kishimoto, M. et al. Mutations and deletions of the CBP gene in human lung cancer. Clin. Cancer Res. 11, 512–519 (2005).
  CAS Google Scholar
• Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360–363 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cromer, M. K. et al. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J. Clin. Endocrinol. Metab. 97, E1774–E1781 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435–439 (2011).
  Article CAS PubMed Google Scholar
• Morin, R. D. et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181–185 (2010).
  Article CAS PubMed Google Scholar
• Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature Genet. 42, 722–726 (2010).
  Article CAS PubMed Google Scholar
• Bodor, C. et al. EZH2 Y641 mutations in follicular lymphoma. Leukemia 25, 726–729 (2011).
  Article CAS PubMed Google Scholar
• Guichard, C. et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genet. 44, 694–698 (2012).
  Article CAS PubMed Google Scholar
• Network, T. C.G. A. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).
  Article CAS Google Scholar
• Stephens, P. J. et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400–404 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539–542 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Biegel, J. A. et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 59, 74–79 (1999).
  CAS PubMed Google Scholar
• Woodson, K. et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J. Natl Cancer Inst. 96, 407–410 (2004).
  Article CAS PubMed Google Scholar
• Yun, K., Soejima, H., Merrie, A. E. H., McCall, J. L. & Reeve, A. E. Analysis of IGF2 gene imprinting in breast and colorectal cancer by allele specific-PCR. J. Pathol. 187, 518–522 (1999).
  Article CAS PubMed Google Scholar
• Nakagawa, M. et al. Expression profile of class I histone deacetylases in human cancer tissues. Oncol. Rep. 18, 769–774 (2007).
  CAS PubMed Google Scholar
• Choi, J. H. et al. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J. Cancer Res. 92, 1300–1304 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Halkidou, K. et al. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59, 177–189 (2004).
  Article CAS PubMed Google Scholar
• Kawai, H., Li, H., Avraham, S., Jiang, S. & Avraham, H. K. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int. J. Cancer 107, 353–358 (2003).
  Article CAS PubMed Google Scholar
• Lin, Z. et al. Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment. Clin. Cancer Res. 15, 570–577 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kleer, C. G. et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl Acad. Sci. USA 100, 11606–11611 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ozdag, H. et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 7, 90 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Huang, B. H. et al. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ. 12, 395–404 (2005).
  Article CAS PubMed Google Scholar
• Wilson, A. J. et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281, 13548–13558 (2006).
  Article CAS PubMed Google Scholar
• Zhang, Z. et al. HDAC6 expression is correlated with better survival in breast cancer. Clin. Cancer Res. 10, 6962–6968 (2004).
  CAS Google Scholar
• Jung-Hynes, B., Nihal, M., Zhong, W. & Ahmad, N. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J. Biol. Chem. 284, 3823–3832 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ashraf, N. et al. Altered sirtuin expression is associated with node-positive breast cancer. Br. J. Cancer 95, 1056–1061 (2006).
  Article CAS Google Scholar
• Lu, P. J. et al. A novel gene (_PLU_-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274, 15633–15645 (1999).
  Article CAS PubMed Google Scholar
• Silva, F. P. et al. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells. Oncogene 27, 2686–2692 (2008).
  Article CAS PubMed Google Scholar
• Northcott, P. A. et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nature Genet. 41, 465–472 (2009).
  Article CAS PubMed Google Scholar
• Peng, D. F. et al. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 27, 1160–1168 (2006).
  Article CAS PubMed Google Scholar
• Saito, Y. et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer 105, 527–532 (2003).
  Article CAS PubMed Google Scholar
• Nakagawa, T. et al. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J. Urol. 173, 1767–1771 (2005).
  Article CAS PubMed Google Scholar
• Agoston, A. T. et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J. Biol. Chem. 280, 18302–18310 (2005).
  Article CAS PubMed Google Scholar
• Butcher, D. T. & Rodenhiser, D. I. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. Eur. J. Cancer 43, 210–219 (2007).
  Article CAS PubMed Google Scholar
• McCarthy, H. et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood 101, 4903–4908 (2003).
  Article CAS PubMed Google Scholar